Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in ApoE-null mice

被引:0
|
作者
Hu, Jie H. [1 ]
Emery, Isaac [1 ]
Krishnan, Ranjini [1 ]
Qian, Kun [1 ]
Du, Liang [1 ]
Buben, Amelia [1 ]
Chu, Talyn [1 ]
Dichek, David [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P462
引用
收藏
页码:E117 / E117
页数:1
相关论文
共 50 条
  • [21] Chylomicronemia due to ApoCIII overexpression in ApoE-null mice: ApoCIII-induced hypertriglyceridemia is not mediated by effects on ApoE
    Ebara, T
    Schachter, NS
    CIRCULATION, 1996, 94 (08) : 4085 - 4085
  • [22] Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice
    Gu, JM
    Johns, A
    Morser, J
    Dole, WP
    Greaves, DR
    Deng, GG
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (01) : 73 - 82
  • [23] Deletion of CCR3 receptor in apoE-/- mice subjected to an atherogenic diet accelerates atherosclerosis
    Domingo, Elena
    Collado, Aida
    Marques, Patrice
    Cervera, Miguel
    Real, Jose T.
    Piqueras, Laura
    Jesus Sanz, Maria
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 122 - 123
  • [24] Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice
    Layne, MD
    Patel, A
    Chen, YH
    Rebel, VI
    Carvajal, IM
    Pellacani, A
    Ith, B
    Zhao, DZ
    Schreiber, BM
    Yet, SF
    Lee, ME
    Storch, J
    Perrella, MA
    FASEB JOURNAL, 2001, 15 (12): : 2733 - +
  • [25] Lack of Mitogen-Activated Protein Kinase Phosphatase-1 Protects ApoE-Null Mice Against Atherosclerosis
    Shen, Jianzhong
    Chandrasekharan, Unni M.
    Ashraf, Mohammad Z.
    Long, Eric
    Morton, Richard E.
    Liu, Yusen
    Smith, Jonathan D.
    DiCorleto, Paul E.
    CIRCULATION RESEARCH, 2010, 106 (05) : 902 - U153
  • [26] Reverse D4F, an Apolipoprotein-AI Mimetic Peptide, Inhibits Atherosclerosis in ApoE-null Mice
    Qin, Shucun
    Kamanna, Vaijinath S.
    Lai, Jack H.
    Liu, Tianjiao
    Ganji, Shobha H.
    Zhang, Linhua
    Bachovchin, William W.
    Kashyap, Moti L.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (03) : 334 - 343
  • [27] Suppressive oligodeoxynucleotides inhibit atherosclerosis in apoE-null mice through modulation of Th1/Th2 balance
    Chen, Y.
    Cheng, X.
    Xie, J. J.
    Yao, R.
    Yu, X.
    Ding, Y. J.
    Tang, T. T.
    Liao, Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 : S51 - S51
  • [28] Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase
    Upmacis, Rita K.
    Crabtree, Mark J.
    Deeb, Ruba S.
    Shen, Hao
    Lane, Paul B.
    Benguigui, Lea Esther S.
    Maeda, Nobuyo
    Hajjar, David P.
    Gross, Steven S.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (05): : H2878 - H2887
  • [29] ENDOTHELIAL-DERIVED VWF, BUT NOT PLATELET-DERIVED, EXACERBATES ATHEROSCLEROSIS IN APOE-NULL MICE BY PROMOTING PLATELET AND LEUKOCYTE ADHESION
    Doddapattar, Prakash
    Dhanesha, Nirav
    Chorawala, Mehul R.
    Tinsman, Chandler
    Jain, Manish
    Nayak, Manasa K.
    Staber, Janice M.
    Chauhan, Anil K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 30 - 30
  • [30] MACROPHAGE SPECIFIC IGF-1 DOWNREGULATES CXCL12 CHEMOKINE AND DECREASES ATHEROSCLEROTIC BURDEN IN APOE-NULL MICE
    Snarski, P.
    Sukhanov, S.
    Yoshida, T.
    Higashi, Y.
    Danchuk, S.
    Shai, S.
    Bysani, C.
    Delafontaine, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 424 - 424